Cel Sci Corporation (CVM)

[NickPar]

From https://clinicaltrials.gov/ct2/show/NCT01265849?term=cel+sci&rank=1

Brief Summary:
The purpose of this study is to determine whether LI administered in combination with cyclophosphamide, indomethacin and zinc (CIZ) in a multivitamin combination prior to standard of care therapy (surgery followed by radiotherapy or concurrent radiochemotherapy) is safe and will increase the overall survival of subjects with previously untreated squamous cell carcinoma of the oral cavity or soft palate at a median of 3 years

Under Study Design:
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2019

By definition Study Completion Date:

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date.

The last participant was September 2016 thus September 2019 is "estimated" completion date.

By definition Primary Completion Date:

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "estimated" primary completion date is the date that the researchers think will be the primary completion date for the study.

IMO the study data will be complete by the end of this month.